Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZAMZ.L Regulatory News (ZAMZ)

  • There is currently no data for ZAMZ

Update on Subsidiary Acquisition

8 Nov 2022 07:00

RNS Number : 6526F
Zamaz PLC
08 November 2022
 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU, WHICH IS PART OF UNITED KINGDOM DOMESTIC LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI 2019/310) ("UK MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION (AS DEFINED IN UK MAR) IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

8 November 2022

 Zamaz plc

"Zamaz" or "the Company"

 Update on Subsidiary Acquisition

Zamaz Plc, the London-based international e-commerce and retail technology business, is pleased to announce that the controlling interest in Eccellenze S.r.l. ("Eccellenze") agreed to be acquired by the Company's wholly-owned subsidiary, Bella Dispensa, has been increased from 70 per cent., as announced on 10 October 2022, to 72.61 per cent.

The aggregate consideration for the acquisition has therefore increased to €438,840, to be satisfied by the issue to the vendors of 3,470,820 new Ordinary shares in Zamaz (the "Acquisition Shares"). Bella Dispensa also has a three year option to acquire the remaining 27.39 per cent. of Eccellenze for an additional € 241,500 in shares.

Eccellenze is a luxury food products business based in Milan with a retail store located on Milan's prestigious Corso Venezia, one of the city's most exclusive and elegant avenues, being part of the upscale Quadrilatero della moda shopping district. Recently established in Q4 2021, Eccellenze has grown rapidly, and now offers over 1,000 premium quality food products in-store. Its highly experienced management team has also developed a unique eno-gastronomic "lifestyle shopping experience" for its growing, highly discerning client base.

Daniele Besnati MD of Bella Dispensa, commented:

" We are delighted to have been able to acquire this additional stake in Eccellenze which provides us with an even greater opportunity to benefit from the very substantial growth in online luxury food and grocery shopping both in Italy and internationally, whilst at the same time further expanding our premium customer base who require and appreciate our ethos of quality and sustainability."

The Company will make appropriate applications to admit the Acquisition Shares to trading and a further announcement in this regard will be made in due course.

For the purposes of UK MAR, the person responsible for arranging release of this announcement on behalf of Zamaz is Martin Groak, Chairman.

 

- Ends -

 

Enquiries:

Zamaz plc

Chris Hill, CEO

www.zamaz.tech 

c/o Walbrook PR Limited 

Walbrook PR Limited

Paul Vann/Nick Rome/Joe Walker

 

Tel: 020 7933 8780

or 07768 807631 

zamaz@walbrookpr.com

 

About Zamaz plc

Zamaz plc is a technology driven e-commerce business that originates, acquires or licenses, operates and scales small and medium-sized brands with category-winning products on global marketplaces. With ever prolific customer data sources, the advent of turnkey e-commerce website platforms, such as Shopify, and a thriving ecosystem of third-party software integrators, the options available to launch and build brands that can be marketed, sold, and shipped online quickly and globally with limited risk have never been more compelling. Such marketplaces, led by Amazon and eBay, also provide connection to millions of consumers, and have become a first-choice route-to-market for a generation of micro and small and medium-sized enterprise businesses.

 

Zamaz mines and analyses data from such online retail technology platforms which provide significant insights into consumer shopping behaviour and trends and enable the business to deploy, market and sell an optimised portfolio of brands, products, packs and prices aligned with active, real-time consumer needs and demands principally on UK and EU Amazon marketplaces.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQUWSNRUVUARRA
12
Date   Source Headline
14th Sep 20237:00 amRNSConfirmation of Name Change to Dispensa Group plc
24th Aug 20237:00 amRNSChange of Name, Board Changes & Accounts Update
31st May 20237:00 amRNSHalf-Year Results to 28 February 2023
27th Mar 20237:00 amRNSTrading Update for Bella Dispensa
21st Mar 202312:10 pmRNSResult of reconvened Bondholders' Meeting
9th Mar 20232:00 pmRNSNotice of Adjourned General Meeting
6th Mar 20237:30 amRNSChange of Registered Office & Company Secretary
21st Feb 20239:05 amRNSSecond Price Monitoring Extn
21st Feb 20239:00 amRNSPrice Monitoring Extension
17th Feb 20232:05 pmRNSSecond Price Monitoring Extn
17th Feb 20232:00 pmRNSPrice Monitoring Extension
17th Feb 20237:00 amRNSNotice of Bondholders' General Meeting
13th Feb 20237:08 amRNSSubsidiary Acquisition
6th Feb 20237:00 amRNSTermination of Convertible Loan Note Facility
1st Feb 20237:00 amRNSResult of AGM & Board & Senior Management changes
16th Jan 20234:40 pmRNSSecond Price Monitoring Extn
16th Jan 20234:35 pmRNSPrice Monitoring Extension
16th Jan 20232:05 pmRNSSecond Price Monitoring Extn
16th Jan 20232:00 pmRNSPrice Monitoring Extension
16th Jan 20237:00 amRNSHoldings in Company & Brand Licence Update
10th Jan 20239:05 amRNSSecond Price Monitoring Extn
10th Jan 20239:00 amRNSPrice Monitoring Extension
6th Jan 20237:00 amRNSNotice of AGM & Posting of Annual Report
6th Jan 20237:00 amRNSDirectorate Changes
5th Dec 20222:05 pmRNSSecond Price Monitoring Extn
5th Dec 20222:00 pmRNSPrice Monitoring Extension
5th Dec 20227:00 amRNS2022 Final Audited Results
2nd Dec 20229:05 amRNSSecond Price Monitoring Extn
2nd Dec 20229:00 amRNSPrice Monitoring Extension
30th Nov 202211:05 amRNSSecond Price Monitoring Extn
30th Nov 202211:00 amRNSPrice Monitoring Extension
28th Nov 20229:05 amRNSSecond Price Monitoring Extn
28th Nov 20229:00 amRNSPrice Monitoring Extension
11th Nov 20225:53 pmRNSIssue of Equity & Total Voting Rights
8th Nov 20227:00 amRNSUpdate on Subsidiary Acquisition
8th Nov 20227:00 amRNSMelloLondon Investor Conference
14th Oct 20227:00 amRNSDirectorate Change
13th Oct 20224:41 pmRNSSecond Price Monitoring Extn
13th Oct 20224:35 pmRNSPrice Monitoring Extension
13th Oct 20222:06 pmRNSSecond Price Monitoring Extn
13th Oct 20222:00 pmRNSPrice Monitoring Extension
13th Oct 202211:05 amRNSSecond Price Monitoring Extn
13th Oct 202211:00 amRNSPrice Monitoring Extension
13th Oct 20229:05 amRNSSecond Price Monitoring Extn
13th Oct 20229:00 amRNSPrice Monitoring Extension
10th Oct 20227:00 amRNSSubsidiary Acquisition
7th Oct 20224:41 pmRNSSecond Price Monitoring Extn
7th Oct 20224:35 pmRNSPrice Monitoring Extension
7th Oct 20222:05 pmRNSSecond Price Monitoring Extn
7th Oct 20222:01 pmRNSPrice Monitoring Extension
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.